Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Motor progression of Parkinson's disease with the leucine-rich repeat kinase 2 G2019S mutation.

Movement disorders : official journal of the Movement Disorder Society - 1 Jul 2014

Yahalom Gilad, Orlev Yael, Cohen Oren S, Kozlova Evgenia, Friedman Eitan, Inzelberg Rivka, Hassin-Baer Sharon

Abstract excerpt

INTRODUCTION: In this retrospective study, we compared motor disease progression in Ashkenazi-Jewish (AJ) Parkinson's disease (PD) patients carrying the LRRK2*G2019S mutation with that of noncarriers. METHODS: Consecutive PD patients were recruited between 2004 and 2011. Disease progression of carriers versus noncarriers was compared using survival analysis, where the end-point was the time from PD onset to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Glycine

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Parkinson Disease

Share to Protein Serine-Threonine Kinases

Source

Identifiers

PMID: 24903616
DOI: 10.1002/mds.25931

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Motor progression of Parkinson's disease with the leucine-rich repeat kinase 2 G2019S mutation.PMID 24903616Read ↗

Progression in the LRRK2-Asssociated Parkinson Disease Population.Semantic proximity Read ↗

Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls.Semantic proximity Read ↗

Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.Semantic proximity Read ↗

Age-specific penetrance ofLRRK2G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 ConsortiumSemantic proximity Read ↗

Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.Semantic proximity Read ↗

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.Semantic proximity Read ↗

Greater motor progression in patients with Parkinson disease who carry LRRK2 risk variants.Semantic proximity Read ↗

The age at onset of LRRK2 p.Gly2019Ser Parkinson’s disease across ancestries and countries of originSemantic proximity Read ↗

Genetic Analysis and Natural History of Parkinson’s Disease Due to the LRRK2 G2019S VariantSemantic proximity Read ↗

The Age at Onset of LRRK2 p.Gly2019Ser Parkinson's Disease Across Ancestries and Countries of Origin.Semantic proximity Read ↗

Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.Semantic proximity Read ↗

Clinical expression of LRRK2 G2019S mutations in the elderly.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.